Loading…
Loading the latest PSX data…
Loading the latest PSX data…
Ferozsons Laboratories Limited (FEROZ), GlaxoSmithKline Pakistan Limited (GLAXO): performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-12
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | FEROZPharmaceuticals | GLAXOPharmaceuticals |
|---|---|---|
| danioPSX score | 39 | 87 |
| Price and size | ||
| Price | Rs 361.42 | Rs 333.18 |
| Today | −0.96% | −1.89% |
| Market cap | Rs 15.7bn | Rs 106.1bn |
| Traded per day | Rs 4m | Rs 51m |
| Valuation and dividends | ||
| P/E | 22.9 | 9.7 |
| Dividend yield | 1.6% | 6.1% |
| EPS (last year) | Rs 14.97 | Rs 31.48 |
| Business | ||
| EPS growth | +23.2% | +53.4% |
| Sales growth | +13.7% | +7.7% |
| Net margin | 4.1% | 15.2% |
| Returns | ||
| 1 month | +7.8% | +6.6% |
| 3 months | −2.3% | −2.9% |
| 1 year | −9.0% | −15.4% |
| vs KSE-100, 1 year | -19.8 pts | -26.3 pts |
| Trend and risk | ||
| 52-week position | 38% | 24% |
| RSI 14 | 57 | 57 |
| RS rank | 43 | 39 |
| Volatility | 41% | 34% |
| Beta | 1.05 | 1.06 |
| danioPSX score | ||
| Value | 16 | 69 |
| Quality | 60 | 81 |
| Dividend | 27 | 64 |
| Momentum | 43 | 34 |
| Safety | 55 | 80 |
| Shariah-compliant | Yes | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener